Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study.
Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study.
复制标题
DOI：
10.1200/go.20.00351
复制
发表时间：
2020-09
影响因子：
4.5
通讯作者：
International Research Network on COVID-19 Impact on Cancer Care
中科院分区：
文献类型：
--
作者：
Jazieh AR;Akbulut H;Curigliano G;Rogado A;Alsharm AA;Razis ED;Mula-Hussain L;Errihani H;Khattak A;De Guzman RB;Mathias C;Alkaiyat MOF;Jradi H;Rolfo C;International Research Network on COVID-19 Impact on Cancer Care
COVID-19大流行影响了全球的医疗系统，导致许多医疗机构的常规护理中断，使脆弱的癌症患者面临重大风险。我们的研究旨在评估这一流行病对全球癌症护理的影响。我们进行了一项横断面研究，使用一个有效的基于网络的问卷调查的51个项目。调查问卷获得了有关这些中心的能力和提供的服务、护理中断的程度、中断的原因、面临的挑战、实施的干预措施以及对大流行期间患者伤害的估计等信息。2020年4月21日至5月8日期间，来自六大洲54个国家的356个中心参加了该活动。这些中心每年为716，979名新癌症患者提供服务。其中大多数（88.2%）报告在大流行期间在提供护理方面面临挑战。虽然55.34%的人减少服务作为先发制人战略的一部分，但其他常见的原因包括系统不堪重负（19.94%），缺乏个人防护设备（19.10%），工作人员短缺（17.98%）和药物限制（9.83%）。46.31%的中心报告了> 10%的患者缺失至少一个周期的治疗。参与者报告患者因癌症特定护理（36.52%）和非癌症相关护理（39.04%）中断而受到伤害，一些中心估计高达80%的患者受到伤害。COVID-19大流行对癌症护理的不利影响是广泛的，全球各中心的影响程度不同。需要进行额外的研究，以评估患者层面的这种影响。
The COVID-19 pandemic affected health care systems globally and resulted in the interruption of usual care in many health care facilities, exposing vulnerable patients with cancer to significant risks. Our study aimed to evaluate the impact of this pandemic on cancer care worldwide. We conducted a cross-sectional study using a validated web-based questionnaire of 51 items. The questionnaire obtained information on the capacity and services offered at these centers, magnitude of disruption of care, reasons for disruption, challenges faced, interventions implemented, and the estimation of patient harm during the pandemic. A total of 356 centers from 54 countries across six continents participated between April 21 and May 8, 2020. These centers serve 716,979 new patients with cancer a year. Most of them (88.2%) reported facing challenges in delivering care during the pandemic. Although 55.34% reduced services as part of a preemptive strategy, other common reasons included an overwhelmed system (19.94%), lack of personal protective equipment (19.10%), staff shortage (17.98%), and restricted access to medications (9.83%). Missing at least one cycle of therapy by > 10% of patients was reported in 46.31% of the centers. Participants reported patient exposure to harm from interruption of cancer-specific care (36.52%) and noncancer-related care (39.04%), with some centers estimating that up to 80% of their patients were exposed to harm. The detrimental impact of the COVID-19 pandemic on cancer care is widespread, with varying magnitude among centers worldwide. Additional research to assess this impact at the patient level is required.